Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 2,406,908 | 2,213,242 | 1,969,058 | 1,775,423 | 1,601,892 |
| Cost of Goods | 1,041,359 | 971,700 | 871,676 | 799,987 | 711,622 |
| Gross Profit | 1,365,549 | 1,241,542 | 1,097,382 | 975,436 | 890,270 |
| Operating Expenses | 813,062 | 750,907 | 685,030 | 626,184 | 590,980 |
| Operating Income | 552,846 | 491,335 | 413,028 | 350,239 | 299,912 |
| Interest Expense | 31,055 | 34,744 | 37,225 | 32,049 | 29,239 |
| Other Income | 427 | 1,151 | 5,254 | 3,656 | 2,468 |
| Pre-tax Income | 522,218 | 457,742 | 381,057 | 321,846 | 273,141 |
| Income Tax | 94,426 | 80,695 | 117,788 | 99,792 | 81,006 |
| Net Income Continuous | 427,792 | 377,047 | 263,269 | 222,054 | 192,135 |
| Minority Interests | 72 | 16 | 125 | 9 | 57 |
| Net Income | $427,720 | $377,031 | $263,144 | $222,045 | $192,078 |
| EPS Basic Total Ops | 4.97 | 4.34 | 3.00 | 2.47 | 2.07 |
| EPS Basic Continuous Ops | 4.97 | 4.34 | 3.00 | 2.47 | 2.07 |
| EPS Diluted Total Ops | 4.89 | 4.26 | 2.94 | 2.44 | 2.05 |
| EPS Diluted Continuous Ops | 4.89 | 4.26 | 2.94 | 2.44 | 2.05 |
| EPS Diluted Before Non-Recurring Items | 4.89 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $640,857 | $574,513 | $496,168 | $429,300 | $370,300 |